Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL849829 | 1.00 | CA2 (0.47) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL7777862 | 1.00 | CA2 (0.47) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL1629287 | 0.98 | CA2 (0.50) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL3960168 | 0.93 | CA2 (0.44) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL12524250 | 0.87 | CA2 (0.40) | CA2GPR84FFAR1LMNAMAPK1 | |
| SCHEMBL20840951 | 0.86 | CA2 (0.47) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL2638231 | 0.86 | GPR84 (0.42) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL16389959 | 0.85 | CA2 (0.52) | CA2MAPTSLC1A2SLC1A1MAPK1 | |
| SCHEMBL13003584 | 0.85 | CA2 (0.50) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL11473599 | 0.84 | CHRM1 (0.44) | CA2GRIK1GRIK2SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1743016-B1 | SOLVATED NONIONIC SURFACTANTS | CRODA UNIQEMA INC (US) | 2012-03-28 | — | — | EP | claimed |
| US-7456139-B2 | Solvated nonionic surfactants | CRODA UNIQEMA, INC. (US) | 2008-11-25 | — | — | US | claimed |
| EP-2919011-B1 | METHOD AND KIT FOR MEASURING COMPONENT TO BE ASSAYED IN SPECIMEN | KYOWA MEDEX CO LTD (JP) | 2018-10-03 | — | — | EP | disclosed |
| EP-2495565-B9 | Method and kit for measuring a component to be assayed in a specimen | KYOWA MEDEX CO LTD (JP) | 2018-03-21 | — | — | EP | disclosed |
| EP-2495565-B1 | Method and kit for measuring a component to be assayed in a specimen | KYOWA MEDEX CO LTD (JP) | 2017-09-20 | — | — | EP | disclosed |
| US-9274125-B2 | Method and kit for measuring component in the presence of fatty acid alkanolamide or nonionic polyoxyethylene surfactant | KYOWA MEDEX CO., LTD. (JP) | 2016-03-01 | — | — | US | disclosed |
| EP-2919011-A1 | METHOD AND KIT FOR MEASURING COMPONENT TO BE ASSAYED IN SPECIMEN | Kyowa Medex CO., LTD. (JP) | 2015-09-16 | — | — | EP | disclosed |
| EP-2495565-A1 | METHOD FOR ASSAYING COMPONENT TO BE ASSAYED IN SPECIMEN AND ASSAY KIT | Kyowa Medex CO., LTD. (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20120219966-A1 | METHOD AND KIT FOR MEASURING COMPONENT TO BE ASSAYED IN SPECIMEN (AS AMENDED) | KYOWA MEDEX CO., LTD. (JP) | 2012-08-30 | — | — | US | disclosed |
| EP-1743016-B1 | SOLVATED NONIONIC SURFACTANTS | CRODA UNIQEMA INC (US) | 2012-03-28 | — | — | EP | disclosed |
| US-20080269094-A1 | Solvated Nonionic Surfactants | ICI AMERICAS, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| EP-1743016-A1 | SOLVATED NONIONIC SURFACTANTS | ICI Americas, Inc. (US) | 2007-01-17 | — | — | EP | disclosed |
| WO-2005111185-A1 | SOLVATED NONIONIC SURFACTANTS | CRODA UNIQEMA INC. (US) | 2005-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269094-A1 | Solvated Nonionic Surfactants | PAOX, FASN, FFAR3 | CA2 627/4885GRIK1 1513/4885GRIK2 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.